Target Name: LOC100129203
NCBI ID: G100129203
Review Report on LOC100129203 Target / Biomarker Content of Review Report on LOC100129203 Target / Biomarker
LOC100129203
Other Name(s): uncharacterized LOC100129203 | Uncharacterized LOC100129203

LOC100129203: A Drug Target / Disease Biomarker

LOC100129203 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling.

LOC100129203 is characterized by its long extracellular domain, which contains a number of well- conserved regions that are involved in its interactions with other proteins. It is composed of four distinct domains: an N-terminus, a transmembrane region, a cytoplasmic region, and an C-terminus.

The N-terminus of LOC100129203 is a 24 amino acid residue long region that is involved in the formation of a disulfide bond. This region is conserved in all members of the GPCR family and is typically involved in the formation of a covalent complex with a protein ligand.

The transmembrane region of LOC100129203 is a 220 amino acid long region that is involved in the formation of a disulfide bond and the conservation of the extracellular domain. This region is conserved in all members of the GPCR family and is involved in the regulation of cellular signaling.

The cytoplasmic region of LOC100129203 is a 100 amino acid long region that is involved in the formation of a disulfide bond and the conservation of the extracellular domain. This region is conserved in all members of the GPCR family and is involved in the regulation of cellular signaling.

The C-terminus of LOC100129203 is a 14 amino acid long region that is involved in the formation of a lysine modification and the conservation of the extracellular domain. This region is conserved in all members of the GPCR family and is involved in the regulation of cellular signaling.

LOC100129203 is a potential drug target because of its involvement in cellular signaling. The N-terminus of LOC100129203 is involved in the formation of a covalent complex with a protein ligand, which suggests that it may be a good target for small molecules that can modulate its activity. Additionally, the transmembrane region and cytoplasmic region of LOC100129203 are involved in the regulation of cellular signaling, which suggests that they may be good targets for drugs that can modulate signaling pathways.

LOC100129203 is also a potential biomarker for certain diseases. For example, it is highly expressed in the brains of individuals with Alzheimer's disease, a progressive neurodegenerative disorder that is characterized by the progressive loss of brain cells. Additionally, LOC100129203 is also expressed in the hearts of individuals with heart failure, a condition that is characterized by the progressive loss of heart muscle.

In conclusion, LOC100129203 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular signaling. It is a member of the GPCR family and is characterized by its long extracellular domain, which contains well- conserved regions that are involved in its interactions with other proteins. Additionally, LOC100129203 is a potential drug target and biomarker for various diseases. Further research is needed to fully understand its role in cellular signaling and its potential as a drug.

Protein Name: Uncharacterized LOC100129203

The "LOC100129203 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100129203 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773